NRCME - National Registry of Certified Medical Examiners Diabetes Mellitus Standards Questions and Answers — Questions and Answers
Question 1: A CMV driver with newly diagnosed insulin-treated diabetes mellitus (ITDM) has stabilized their condition. According to FMCSA standards, what is the primary requirement before the Certified Medical Examiner (CME) can consider certification?
- The driver must complete a mandatory 6-month waiting period without any hypoglycemic events.
- The driver must have their treating clinician complete the Insulin-Treated Diabetes Mellitus Assessment Form, MCSA-5870. (Correct answer)
- The driver must first obtain a Skills Performance Evaluation (SPE) certificate.
- The driver must be evaluated by an FMCSA-appointed endocrinologist.
Correct answer: The driver must have their treating clinician complete the Insulin-Treated Diabetes Mellitus Assessment Form, MCSA-5870.
The current FMCSA process requires that the driver's own treating clinician (TC) evaluates their diabetes management and completes the MCSA-5870 form. The CME then uses this form, which must be completed within 45 days of the exam, to help make the certification decision.
Question 2: A 55-year-old driver with type 2 diabetes, managed effectively with diet and an oral medication (metformin), presents for a recertification exam. He has no evidence of target organ damage and his blood sugar logs show good control. What is the maximum certification period for this driver?
- 6 months
- 2 years
- 1 year (Correct answer)
- 3 months
Correct answer: 1 year
Even when non-insulin-treated diabetes is well-controlled, the FMCSA views it as a condition that can progress and develop complications. Therefore, the maximum certification period is limited to one year to allow for annual monitoring of the condition.
Question 3: Which of the following findings related to diabetic retinopathy is considered an absolute and permanent disqualification for a commercial motor vehicle driver?
- Mild background diabetic retinopathy.
- Severe nonproliferative or proliferative diabetic retinopathy. (Correct answer)
- A history of laser photocoagulation therapy.
- Absence of retinopathy but a diagnosis of diabetes for over 10 years.
Correct answer: Severe nonproliferative or proliferative diabetic retinopathy.
FMCSA regulations permanently disqualify any driver diagnosed with severe non-proliferative diabetic retinopathy or proliferative diabetic retinopathy. These conditions present a significant and unpredictable risk of sudden vision loss, which is incompatible with the safe operation of a CMV.
Question 4: A driver with insulin-treated diabetes mellitus (ITDM) had a severe hypoglycemic episode, defined as requiring the assistance of another person, one month ago. What is the correct determination for their current certification status?
- The driver is disqualified and prohibited from operating a CMV. (Correct answer)
- The driver can be certified for 3 months if their treating clinician provides a clearance letter.
- The driver can be certified for a maximum of 6 months after a one-month waiting period.
- The driver is qualified if they now have a continuous glucose monitor (CGM).
Correct answer: The driver is disqualified and prohibited from operating a CMV.
A severe hypoglycemic episode, defined as one requiring the assistance of others, results in the driver being prohibited from operating a CMV. The driver must be evaluated by their treating clinician (TC), who must determine the cause has been addressed and the driver is again stable. The TC must complete a new MCSA-5870 form before the driver may resume operating a CMV.
Question 5: To be eligible for the maximum 12-month medical certificate, a driver with insulin-treated diabetes mellitus (ITDM) must provide their treating clinician with what minimum duration of blood glucose self-monitoring records?
- The preceding 1 month of records.
- The preceding 3 months of records. (Correct answer)
- The preceding 6 months of records.
- The preceding 12 months of records.
Correct answer: The preceding 3 months of records.
FMCSA regulations require that an ITDM individual must provide at least the preceding 3 months of blood glucose self-monitoring records to their treating clinician for review. If a driver does not have 3 months of records, the medical examiner has the discretion to issue a certificate for up to 3 months to allow time to gather the required data.
Question 6: A CMV driver is well-managed on an insulin pump for Type 1 diabetes. During a recertification exam, the medical examiner counsels him on safe driving practices. Which of the following is a key FMCSA recommendation for blood glucose monitoring while on duty?
- Test blood glucose only when symptoms of hypoglycemia occur.
- Test blood glucose once before starting a shift and again at the end.
- Test blood glucose levels at least every 6 hours while driving.
- Test blood glucose before driving and approximately every 2 to 4 hours while driving. (Correct answer)
Correct answer: Test blood glucose before driving and approximately every 2 to 4 hours while driving.
For drivers with ITDM, frequent blood glucose monitoring is essential for safety. The Canadian Diabetes Association guidelines, which are often referenced in safety discussions, recommend testing within an hour before driving and every 4 hours while driving. This proactive monitoring helps prevent hypo- or hyperglycemic events that could impair driving ability.
